Depo-Provera Brain Tumor Lawsuit | Free Case Review | VictimsOfTheShot.com
VictimsOfTheShot.com
National Legal Review

Did You Develop a Brain Tumor After Taking Depo-Provera?

Recent studies link the Depo-Provera birth control shot to a significantly increased risk of developing meningiomas (brain tumors). If you or a loved one suffered this devastating diagnosis,you may be entitled to significant financial compensation.

Fill out the form to get started
No Obligation

Free Case Evaluation

Takes less than 2 minutes to see if you qualify.

Your information is 100% secure and confidential

Free Case Evaluation

Completely confidential and zero obligation to proceed.

No Fee Unless You Win

We operate on a contingency basis. You pay nothing out of pocket.

Experienced Legal Network

Connect with attorneys who understand complex pharmaceutical litigation.

The Link Between Depo-Provera and Meningiomas

Meningiomas are typically non-cancerous brain tumors, but their location in the brain and spinal cord means they can cause severe, life-altering symptoms and often require invasive surgery.

What the Studies Show

Recent medical studies, including a major 2024 study published in the BMJ (British Medical Journal), have found that prolonged use of certain progestogen medications—including the active ingredient in Depo-Provera (medroxyprogesterone acetate)—is associated with a significantly increased risk of developing meningioma brain tumors.

Common Symptoms of Meningioma

If you have used Depo-Provera and experienced any of the following, it is critical to consult a medical professional:

  • Persistent or worsening headaches
  • Changes in vision (blurred or double vision)
  • Hearing loss
  • Memory loss or confusion
  • Seizures
  • Weakness in arms or legs

Why Legal Action is Happening

Manufacturers have a legal duty to warn patients and doctors about severe risks associated with their medications. Lawsuits allege that the makers of Depo-Provera failed to adequately warn users about the increased risk of developing these brain tumors, depriving women of the ability to make an informed choice about their health.

Frequently Asked Questions

Q
Who qualifies for the Depo-Provera lawsuit?

Generally, women who received Depo-Provera injections (at any point since 1992) and were subsequently diagnosed with a meningioma brain tumor may qualify. The best way to know is to complete our free case evaluation.

Q
How much does it cost to hire a lawyer?

Nothing out of pocket. Our network attorneys work on a contingency fee basis. This means they only get paid if they successfully recover compensation for you. If you don't win, you pay no legal fees.

Q
What kind of compensation could I receive?

Compensation varies by case but may include past and future medical expenses, lost wages, pain and suffering, and emotional distress caused by the diagnosis and subsequent treatments like brain surgery.

Q
Is there a time limit to file a claim?

Yes. Every state has a 'statute of limitations' which legally limits the time you have to file a lawsuit after your diagnosis or injury. It is critical to act quickly to preserve your legal rights.

Don't Let Time Run Out on Your Claim

Find out if you qualify for compensation. The review is free, confidential, and carries no obligation.

VictimsOfTheShot.com

Dedicated to helping women affected by Depo-Provera obtain the financial compensation they deserve. Our network of experienced legal professionals is here to fight for your rights.

100% Confidential
No Win, No Fee

Legal Disclaimer

This website is a legal advertisement and lead generation service. The information provided on this site is not legal advice, does not constitute a lawyer referral service, and no attorney-client or confidential relationship is or will be formed by use of the site.

Submitting your information does not guarantee representation. Cases may be referred to other attorneys. Do not stop taking any medication without first consulting your doctor. Past results do not guarantee future outcomes.

© 2026 VictimsOfTheShot.com. All rights reserved.